Now I have enough information to write the final consolidated review. Let me synthesize all reviewer inputs with the paper text.

---

## Summary

TrajGPT is a generative pre-trained Transformer for irregularly-sampled longitudinal health data (EHRs). Its core contribution is a Selective Recurrent Attention (SRA) mechanism with a data-dependent decay (γ) that can be interpreted as discretized first-order ODEs under ZOH, enabling a proposed "time-specific inference" that queries the model at arbitrary future timestamps rather than auto-regressively stepping. Evaluated on PopHR (489K patients) and eICU across forecasting, drug prediction, and phenotype classification tasks in zero-shot, few-shot, and fine-tuning settings.

---

## Strengths

- **Large-scale pre-training with genuine clinical scope.** Training on ~489K PopHR patients with diverse downstream tasks (forecasting, zero-shot classification) goes well beyond most prior irregular-time-series papers. The scale and task diversity are a meaningful step toward EHR foundation models.
- **Theoretical connection between SRA and ODEs.** Appendices C/D provide a derivation linking the recurrent state update to ZOH discretization of a continuous-time linear ODE (Eq. 5). This connection is principled and enables the time-specific inference idea.
- **Empirical breadth.** Two datasets, three downstream tasks, multiple settings (zero-shot/few-shot/full), and a large set of baselines including both Transformer variants and specialized irregular-time methods. The parallel/recurrent duality enables efficient training (O(N)) and O(1) per-point inference complexity.
- **Data-dependent decay for clinical adaptation.** The architecture's ability to assign slower decay to chronic conditions and faster decay to acute events is conceptually sound for clinical time series, and is (at least qualitatively) supported by the embedding visualization in Figure 3.
- **Ablation validates time-specific inference.** Table 3 consistently shows a gap of ~4.6–6.2 pp for time-specific vs. auto-regressive inference across all rows, which is the paper's main forecasting advantage.

---

## Weaknesses

### Fatal
*(None that conclusively invalidate the paper, though see Major #1 and #2 below for issues that, if confirmed, would be serious.)*

---

### Major

**1. Time-specific inference is underspecified and potentially circular — this is the most critical methodological concern.**
Section 3.2 states the target state update as $S_{n'} = D_{\Delta_{t_{n'},n}} S_n + K_{n'}^\top V_n$, and the output as $O_{n'} = Q_{n'} S_{n'}$. From Eq. (1), both $Q_{n'} = X_{n'} W_Q e^{i\theta t_{n'}}$ and $K_{n'} = X_{n'} W_K e^{-i\theta t_{n'}}$ require the content embedding $X_{n'}$ — i.e., the unknown observation being predicted. The paper simultaneously says "TrajGPT utilizes both the target timestep $t_{n'}$ and the **last observation** $(x_n, t_n)$" (emphasis ours), which hints the last content may be reused. But that interpretation (e.g., $K_{n'} = X_n W_K e^{-i\theta t_{n'}}$) is never stated. As written, the inference rule appears to require the target token to predict itself. Since the headline empirical advantage over auto-regressive inference (up to +6.2 pp in Table 3) is attributed entirely to this inference mode, this ambiguity is not a clarification issue — the core forecasting claim cannot be verified from the paper's own notation. The authors must precisely specify what $X_{n'}$ is at inference time.

**2. Zero-shot classification mechanism is never operationally defined.**
The paper reports AUPRC values for zero-shot insulin, CHF, and sepsis classification but does not describe the scoring procedure at any point. Section 5.1 shows that positive and negative patients form visually separable UMAP clusters (Fig. 3b), but UMAP plots do not themselves produce class scores. The actual mechanism — nearest-centroid, cosine similarity, token probability, or something else — is absent from both the main text and the appendix. AUPRC is highly sensitive to the choice of score; without specification, these zero-shot results cannot be reproduced and the claim "without requiring task-specific fine-tuning" cannot be evaluated. This is a core claim of the paper, not a peripheral detail.

**3. Ablation is too narrow and contains a missing entry.**
Table 3 ablates only the K=10 forecasting metric on PopHR. None of the classification tasks (insulin, CHF, sepsis) — where zero-shot performance is the paper's most distinctive claim — are ablated. The entry for "TrajGPT (without Pre-training) | Auto-regressive" is explicitly left as "?" in Table 3, preventing any assessment of whether pre-training is necessary for the key inference strategy. This gap directly affects the interpretation of what drives performance.

**4. The data-dependent decay — the paper's stated architectural novelty — contributes only marginally in the ablation.**
Table 3 shows that removing decay gating drops K=10 recall by only 1.4 pp (71.7 → 70.3), while removing RoPE drops by 3.9 pp and the inference strategy gap is 4.6–6.2 pp. The paper introduces SRA as the key novel component, but the ablation indicates that the main performance driver is the inference method, not the selective decay. The introduction's framing of data-dependent decay as the "key missing ingredient" is not supported by the ablation evidence.

**5. Asymmetric pre-training disadvantages some baselines, making comparisons harder to interpret.**
Section 4.4 states that "other models without an established pre-training paradigm" use a generic 40% masking objective (Zerveas et al., 2021), while TrajGPT uses its natural next-token prediction objective. Some irregular-time baselines are trained from scratch. The zero-shot and few-shot comparisons thus mix models with their native pre-training setup (TrajGPT) against models with a weaker, mismatched pre-training. This does not invalidate the results, but it makes it difficult to isolate whether gains come from the architecture or the training paradigm.

---

### Minor

- **Several headline results are within overlapping standard-error ranges.** On PopHR K=10, TrajGPT gets 71.7 ± 2.6 vs. TimelyGPT 70.3 ± 3.1 and MTand 70.2 ± 2.5 — not a statistically clear win. On eICU K=10 and K=20, differences are similarly marginal. The paper's language ("TrajGPT excels") does not reflect this uncertainty.
- **TrajGPT is not best in several fine-tuned settings.** On PopHR CHF, mTAND reaches 85.4 vs. TrajGPT 83.9. On eICU fine-tuned sepsis, MTand reaches 52.5 vs. 51.3 for TrajGPT. The paper acknowledges these cases at the sentence level, but the abstract's blanket claim of superiority is not accurate.
- **ODE/continuous-dynamics claims are not empirically validated.** Section 3.2 and Figure 2 assert that TrajGPT "enables interpolation and extrapolation by modeling continuous dynamics." The evidence for this is exclusively two cherry-picked patient case studies in Section 5.3. No quantitative interpolation accuracy (e.g., hold-out intermediate observations) is provided, and the "risk growth" visualization in Figure 4 uses token probability differences rather than a validated clinical model.
- **Broken figure cross-reference.** Section 5.1 references "Fig. ??" for the decay vector visualization, indicating an incomplete manuscript.
- **Interpolation procedure unclear.** Section 3.2 states "for interpolation, it simply evolves the dynamics within the observed timeframe using a unit discretization step size" — but the model's step size Δ is defined as the gap between irregular observations. Using unit steps inside observed intervals is disconnected from this definition and is not reconciled.

---

### Trivial

- Missing value handling within visit sequences is not discussed (EHR data often has within-visit missing measurements). Not a core concern given the discrete-code formulation, but worth noting.
- The RoPE timestamp encoding (Eq. 1 with $e^{i\theta t_n}$) uses raw timestamps without discussion of scaling or normalization, which can affect the encoding for large absolute ages or long intervals.

---

## Nice-to-Haves

- Empirical validation of interpolation: hold out a subset of intermediate observations and measure reconstruction error against a neural ODE baseline (ODE-RNN, ContiFormer). This would directly test the ODE interpretation claim.
- Analysis of learned γ distributions: visualize actual per-patient γ values for chronic vs. acute conditions to substantiate the "selective forgetting" narrative beyond anecdote.
- Extend ablation to classification tasks to isolate whether SRA or pre-training paradigm drives zero-shot AUPRC.
- Comparison with general time-series foundation models (Chronos, Lag-Llama, MOIRAI) on zero-shot evaluation, given that this is the paper's primary claim — currently deferred to future work but relevant now.
- Evaluation on a public standard benchmark (e.g., PhysioNet) alongside EHR datasets to allow external reproducibility.

---

## Removed Points

*These points are flagged to be removed; treat them with caution.*

- **"BitMimicGPT" typo** (Neutral reviewer, point 4): Pure formatting/style nitpick — removed per hard rules.
- **"PopHR is proprietary, results cannot be independently verified"** (Spark): The paper cites this dataset and the model is also evaluated on eICU, which is public. Reproducibility concerns rooted in dataset availability are removed per hard rules.
- **Comparison with RetNet/Retentive Network** (Spark "obvious next step"): Invoking a specific unverified missing related work — removed per hard rules.
- **"Undisclosed hyperparameters / training details"** (implied by Human Finder #5): Requesting complete runtime logs or exhaustive hyperparameter sweeps falls under the trivial reproducibility nitpick category — removed.
- **Criticism that mTAND beats TrajGPT therefore TrajGPT is not good overall** (Harsh): The paper explicitly acknowledges mTAND's superiority in CHF and fine-tuned sepsis. The asymmetry on those tasks favors the baseline, not the authors' method, so this cannot be used to dismiss the paper's contributions per hard rules.
- **"Cannot verify independence of cited datasets/tools"**: Any such claim removed per hard rules.

---

## Novel Insights

The strongest insight across all three reviewers — largely underweighted in the paper itself — is that the performance gain in TrajGPT comes primarily from the *inference strategy* (time-specific, +4.6–6.2 pp) rather than from the architectural novelty of data-dependent decay (+1.4 pp). This is counter to the paper's own narrative, which emphasizes the SRA mechanism as the key contribution. A paper reframed around "ODE-grounded time-specific inference as a principled alternative to autoregressive decoding for irregular time series" would be more accurate and arguably more impactful than one emphasizing selective decay. The ODE connection is the real enabling theoretical contribution; the gating is auxiliary. This reframing could substantially strengthen future versions.

---

## Suggestions

1. **Clarify time-specific inference: explicitly state what $X_{n'}$ is used to compute $Q_{n'}$ and $K_{n'}$ during inference.** If the last observed token's content embedding is reused with the target timestamp (i.e., $K_{n'} = X_n W_K e^{-i\theta t_{n'}}$), state this precisely. This is the single most important fix.
2. **Define and publish the zero-shot scoring procedure** — nearest centroid, softmax probability of a target class token, or otherwise — so AUPRC results are reproducible.
3. **Complete Table 3**: fill in the missing "?" entry and add zero-shot classification ablation rows.
4. **Reframe the paper's contribution narrative** to emphasize time-specific ODE-grounded inference as the primary advance, with data-dependent decay as an architectural refinement supported by the empirical results.
5. **Add quantitative interpolation experiments** on held-out timestamps to substantiate the ODE/continuous-dynamics claims.

---

## Score and Decision

**Calibration:**

| Paper | Decision | Scores | Closest resemblance |
|---|---|---|---|
| MOTOR (NialiwI2V6) | Accept (spotlight) | 8,8,6,8 | EHR foundation model, comprehensive evaluation, 55M patients, clear methodology |
| Interpretable Pre-Trained Transformers (eciCtsqGc8) | Reject | 8,8,6 | GPT for healthcare time-series, good concept but limited scope |
| TACD-GRU (zwuemuTiN8) | Reject | 5,5,5,6 | Irregular time-series, competitive baselines, missing analyses |
| GITAR (tkN0sLhb4P) | Reject | 3,6,5,5 | Irregular time-series pre-training, missing motivation and weaker experiments |

TrajGPT sits between GITAR/TACD-GRU and MOTOR. It is substantially more comprehensive than GITAR (larger datasets, more tasks), has a clear theoretical motivation, and includes both zero-shot and few-shot evaluations. However, it falls well short of MOTOR's scale, validation quality, and methodological clarity. The two major unresolved issues (time-specific inference circularity, undefined zero-shot scoring) are not cosmetic; they concern the two most important empirical claims. The data-dependent decay — the stated architectural novelty — shows only marginal benefit in the ablation. This profile (interesting direction, real but modestly supported contributions, underspecified core mechanisms) is consistent with the 5.0–5.5 range of TACD-GRU.

**Final assessment:**
- **Originality:** Moderate. The ODE-SRA connection is genuinely novel; the data-dependent decay is incremental over RetNet-style work.
- **Importance:** Meaningful — EHR trajectory modeling at scale is a real need.
- **Claim support:** Weak-to-moderate. Major claims (time-specific inference, zero-shot classification) rest on underspecified mechanics.
- **Experimental soundness:** Adequate breadth, but marginal effect sizes, cherry-picked case studies, and an incomplete ablation.
- **Writing clarity:** Generally clear, but Section 3.2 (time-specific inference) and zero-shot scoring are critical underspecified gaps.
- **Community value:** The large-scale PopHR experiments and the ODE framing are useful; the paper would be more valuable with the gaps above addressed.

**Score: 5.0 (Borderline Reject)**

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>